CDK2 and colon carcinoma: Despite the initial setbacks that CDK2 inhibition by anti-CDK2 shRNA, antisense oligonucleotides, a dominant-negative CDK2, or overexpression of p27Kip1 failed to arrest the proliferation of colon carcinoma cells [193].